Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 USD | -8.73% | -20.72% | -44.71% |
Sales 2024 * | 7.3M 5.33M | Sales 2025 * | 9.12M 6.67M | Capitalization | 1.91M 1.39M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.26 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc.
1 day | -8.73% | ||
1 week | -20.72% | ||
Current month | -36.81% | ||
1 month | -33.68% | ||
3 months | -36.90% | ||
6 months | -59.67% | ||
Current year | -44.71% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.23 | -8.73% | 478,442 |
24-04-25 | 0.252 | -16.83% | 623,391 |
24-04-24 | 0.303 | +10.99% | 3,609,547 |
24-04-23 | 0.273 | -2.47% | 93,323 |
24-04-22 | 0.2799 | -3.50% | 201,283 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.71% | 1.39M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INM Stock